Stay updated on Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.

Latest updates to the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page
- ChecktodayChange DetectedThe page revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a site/version update without changing the study details.SummaryDifference0.1%

- Check8 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded Small cell lung carcinoma as a topic and added a new 'Genetic and Rare Diseases Information Center' resource under Resources.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision updated to v3.5.0 (added) and v3.4.3 (removed). This change is limited to page metadata and does not affect the study content or user interactions.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.4.2 is now displayed; this appears to be a minor site revision with no changes to the study content, eligibility criteria, or results.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. No substantive changes to the study information are indicated.SummaryDifference0.1%

Stay in the know with updates to Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.